Passali Desiderio, Cingi Cemal, Staffa Paola, Passali Francesco, Muluk Nuray Bayar, Bellussi Maria Luisa
Department of Otorhinolaryngology - Head and Neck Surgery, University of Siena, 53100 Siena, Italy.
Department of Otorhinolaryngology - Head and Neck Surgery, Osmangazi University, Faculty of Medicine, 26040 Eskisehir, Turkey.
Asia Pac Allergy. 2018 Jan 25;8(1):e7. doi: 10.5415/apallergy.2018.8.e7. eCollection 2018 Jan.
Allergic rhinitis (AR) is a global health problem and is characterised by one or more symptoms, including sneezing, itching, nasal congestion and rhinorrhea.
We investigated the features of AR and the physician's approach to the management of AR patients in four geographical regions.
In this cross-sectional study, a questionnaire survey concerning AR was completed by Honorary and Corresponding Members of the Italian Society of Rhinology from different countries among 4 world geographical regions-Asia, Europe, the Americas, and Africa.
The prevalence of AR was reported to be 15%-25%. Children and adolescents, as well as young adults, were the age groups more affected by AR with comorbidities of asthma, sinusitis, conjunctivitis, and nasal polyposis. Nasal symptoms of AR were more intense in the spring (51.92%) and autumn (28.85%). The most common aero-allergens were pollen and mites (67.31%), animal dander and pollutants (23.08%), and fungal allergens (21.15%). Allergen-specific immunotherapy was prescribed for both perennial and seasonal allergens (32.69%) via sublingual swallow (46.15%) and subcutaneous (32.69%) routes. For the AR patients, the most prescribed drugs were intranasal corticosteroids (86.54%) and oral H-antihistamines (82.69%).
A network of experts can improve our knowledge concerning AR epidemiology, and together with guidelines, could assist practitioners and otolaryngologists in standardising the diagnosis and treatment of AR.
变应性鼻炎(AR)是一个全球性的健康问题,其特征为一种或多种症状,包括打喷嚏、瘙痒、鼻塞和流涕。
我们调查了四个地理区域中AR的特征以及医生对AR患者的管理方法。
在这项横断面研究中,来自世界四个地理区域(亚洲、欧洲、美洲和非洲)不同国家的意大利鼻科学会名誉会员和通讯会员完成了一项关于AR的问卷调查。
据报告,AR的患病率为15%-25%。儿童、青少年以及年轻人是受AR影响且合并哮喘、鼻窦炎、结膜炎和鼻息肉的年龄组。AR的鼻部症状在春季(51.92%)和秋季(28.85%)更为严重。最常见的空气变应原是花粉和螨虫(67.31%)、动物皮屑和污染物(23.08%)以及真菌变应原(21.15%)。通过舌下含服(46.15%)和皮下注射(32.69%)途径,针对常年性和季节性变应原均开具了变应原特异性免疫疗法(32.69%)。对于AR患者,最常开具的药物是鼻用糖皮质激素(86.54%)和口服H1抗组胺药(82.69%)。
专家网络可以增进我们对AR流行病学的了解,并与指南一起,帮助从业者和耳鼻喉科医生规范AR的诊断和治疗。